Abstract
The isoquinolinone-based tetracyclic compounds were designed and synthesized and their PARP-1 inhibitory activity was evaluated. Most of synthesized compounds showed fairly good activity. Also the most active compound 6 showed its activity on potentiation of anticancer agents, temozolamide and etoposide, by 1.7 times, respectively.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / toxicity
-
Cell Line, Tumor
-
DNA Damage
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / toxicity
-
Heterocyclic Compounds, 4 or More Rings / chemical synthesis*
-
Heterocyclic Compounds, 4 or More Rings / chemistry
-
Heterocyclic Compounds, 4 or More Rings / toxicity
-
Humans
-
Isoquinolines / chemical synthesis*
-
Isoquinolines / chemistry
-
Isoquinolines / pharmacology
-
Poly(ADP-ribose) Polymerase Inhibitors
-
Poly(ADP-ribose) Polymerases / metabolism
-
Quinolones / chemistry*
Substances
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
Heterocyclic Compounds, 4 or More Rings
-
Isoquinolines
-
Poly(ADP-ribose) Polymerase Inhibitors
-
Quinolones
-
methyl-6H-pyrido(2',1'-1,2)imidazo(5,4-c)isoquinolin-5-one
-
Poly(ADP-ribose) Polymerases